Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X-Reference-Cited by-同舟云学术

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X

Published:2015-12 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Antonios Gregory,Borgers Henning,Richard Bernhard C.,Brauß Andreas,Meißner Julius,Weggen Sascha,Pena Vladimir,Pillot Thierry,Davies Sarah L.,Bakrania Preeti,Matthews David,Brownlees Janet,Bouter Yvonne,Bayer Thomas A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep17338.pdf

Reference42 articles.

1. Selkoe, D. J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer’s disease. Trends Cell Biol. 8, 447–453 (1998).

2. Selkoe, D. J. Alzheimer’s disease: genes, proteins and therapy. Physiol. Rev. 81, 741–766 (2001).

3. Klein, W. L. Abeta toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345–352 (2002).

4. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8, 101–112 (2007).

5. Wilcox, K., Lacor, P., Pitt, J. & Klein, W. Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease. Cell. Mol. Neurobiol. 31, 939–948 (2011).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of the 3D conformation of a small peptide vaccine targeting Aβ42 oligomers;Physical Chemistry Chemical Physics;2024

2. A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model;International Journal of Molecular Sciences;2023-01-21

3. Search strategy analysis of Tg4-42 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficits;Scientific Reports;2022-03-31

4. Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s disease;Cellular and Molecular Life Sciences;2022-03

5. Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis;Cellular and Molecular Life Sciences;2021-12-16